CompletedPhase 3

Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin

NCT01632163

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Investigational Site Number 156001

Beijing, China

+50 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2012-10
Enrollment: 447 participants
Sponsor: Sanofi
Purpose: treatment

Locations (51)

Investigational Site Number 156001Beijing, China
Investigational Site Number 156033Beijing, China
Investigational Site Number 156006Beijing, China
Investigational Site Number 156005Beijing, China
Investigational Site Number 156004Beijing, China
Investigational Site Number 156002Beijing, China
Investigational Site Number 156016Changchun, China
Investigational Site Number 156025Changsha, China
Investigational Site Number 156014Chengdu, China
Investigational Site Number 156013Chengdu, China
Investigational Site Number 156034Dalian, China
Investigational Site Number 156035Fuzhou, China
Investigational Site Number 156021Guangzhou, China
Investigational Site Number 156023Haikou, China
Investigational Site Number 156017Harbin, China
Investigational Site Number 156026Jinan, China
Investigational Site Number 156029Jinan, China
Investigational Site Number 156019Nanjing, China
Investigational Site Number 156020Nanjing, China
Investigational Site Number 156018Qingdao, China
Investigational Site Number 156028Shanghai, China
Investigational Site Number 156007Shanghai, China
Investigational Site Number 156032Shenyang, China
Investigational Site Number 156009Shijiazhuang, China
Investigational Site Number 156036Siping, China
Investigational Site Number 156010Suzhou, China
Investigational Site Number 156008Tianjin, China
Investigational Site Number 156027Wuhan, China
Investigational Site Number 156011Xi'an, China
Investigational Site Number 156012Xi'an, China
Investigational Site Number 356019Ahmedabad, India
Investigational Site Number 356018Aligarh, India
Investigational Site Number 356026Bangalore, India
Investigational Site Number 356017Bhubaneswar, India
Investigational Site Number 356002Hyderabad, India
Investigational Site Number 356024Hyderabad, India
Investigational Site Number 356015Nagpur, India
Investigational Site Number 356008Pune, India
Investigational Site Number 356021Secunderabad, India
Investigational Site Number 356023Visakhapatnam, India
Investigational Site Number 643007Kirov, Russia
Investigational Site Number 643003Saint Petersburg, Russia
Investigational Site Number 643004Saint Petersburg, Russia
Investigational Site Number 643005Saint Petersburg, Russia
Investigational Site Number 643006Samara, Russia
Investigational Site Number 410003Daegu, South Korea
Investigational Site Number 410007Goyang, South Korea
Investigational Site Number 410006Seoul, South Korea
Investigational Site Number 410001Seoul, South Korea
Investigational Site Number 410005Seoul, South Korea
Investigational Site Number 410002Wŏnju, South Korea